ASCO develops and publishes clinical practice guidelines, provisional clinical opinions (PCOs), and guideline endorsements, providing evidence-based recommendations to serve as a guide for doctors and outline appropriate methods of treatment and care. The guidelines can also address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented).

The Clinical Practice Guidelines Committee (CPGC)

ASCO Clinical Guidelines are developed through a multi-stage process. First, the Guideline Advisory Groups (AGs) identify and prioritize topics for guideline development, and make recommendations to the Clinical Practice Guidelines Committee (CPGC). The (CPGC) is then charged with the responsibility of approving the topics on behalf of the ASCO Board of Directors. Topics for guidelines are selected on the basis of significant clinical or economic importance; presence of variations in patterns of, or access to, care; availability of suitable data; and ethical considerations.

Each spring, a survey will be launched to provide ASCO members the opportunity to submit topics for guideline development. After the survey closes, member-suggested topics will be provided to the appropriate Guideline Advisory Group (AG) for review during their annual priority setting process. We welcome you to submit a topic via our online form. 

Practice Guidelines Implementation Network (PGIN) 

ASCO has created the Practice Guidelines Implementation Network (PGIN) to raise awareness about its evidence-based recommendations on cancer care. PGIN aids in disseminating and implementing ASCO Clinical Practice Guidelines and associated Clinical Tools and Resources.

To comment on published guidelines or provide new evidence, visit the ASCO Guidelines Wiki.

Guidelines containing this symbol indicate an associated QOPI® Measure.

Random Quote

"Precision medicine has begun to transform the lives of many patients with cancer, but its application in clinical practice is enormously complex. ASCO hopes to contribute to and advance the field by providing oncologists with the training, tools, and data they need."
Richard L. Schilsky, MD, FACP, FASCO
ASCO Chief Medical Officer